Overview
- 87 inspections across 79 sites are on record.
- 361 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-12-19.
At a glance
Inspections
87
Sites
79
Observations
361
Career since
Nov 2014
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| F.H. INVESTMENTS, Inc. | 19 Dec 2025 | Human Drugs | On file |
| Park Avenue Compounding | 23 Sep 2025 | Human Drugs | View 483 → |
| Central Admixture Pharmacy Services, Inc. | 31 Jul 2023 | Human Drugs | View 483 → |
| Nephron Sterile Compounding Center, LLC | 10 Feb 2023 | Human Drugs | View 483 → |
| Eagle Pharma Outsourcing LLC | 12 Aug 2021 | Human Drugs | View 483 → |
Sites inspected
F.H. INVESTMENTS, Inc.Birmingham, United States1 insp.
Park Avenue CompoundingSaint Louis, United States1 insp.
Central Admixture Pharmacy Services, Inc.Phoenix, United States1 insp.
Nephron Sterile Compounding Center, LLCWest Columbia, United States1 insp.
Eagle Pharma Outsourcing LLCHoover, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Meocha V Whaley5 shared
Zada L Giles4 shared
Marie B Buen-Bigornia3 shared
Marvin D Jones3 shared
Laura L Staples3 shared
Mary-Jeanet Mcgarry2 shared
Melinda Lee2 shared
Demario L Walls2 shared
Brandon C Heitmeier2 shared
Nancy M Espinal2 shared
Full investigator report
Get the verbatim findings behind June P Page's 361 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site